Dosage Forms

Apr 11, 2018
Equipment and Processing Report
New filling and inspection machines and new containers and closures for injectable drugs will be on display at INTERPHEX 2018.
Apr 10, 2018
By Pharmaceutical Technology Editors
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
Apr 09, 2018
By Pharmaceutical Technology Editors
Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.
Apr 09, 2018
By Pharmaceutical Technology Editors
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
Apr 09, 2018
By Pharmaceutical Technology Editors
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
Apr 06, 2018
By Pharmaceutical Technology Editors
Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.
Apr 06, 2018
By Pharmaceutical Technology Editors
Anthony Qu, PhD, vice president of Scientific Affairs at Halo Pharma, will give a presentation on fixed-dose combination products, drug products containing multiple active ingredients, as an effective approach for simplified dosing at CPhI North America on Wednesday, April 25, 2018 in Philadelphia, PA.
Apr 05, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.
Apr 05, 2018
By Pharmaceutical Technology Editors
Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.
Apr 05, 2018
By Pharmaceutical Technology Editors
The European approval marks the first approval for a biosimilar in that region resulting from the companies’ joint portfolio.
native1_300x100
lorem ipsum